Late Breaking Abstract - Target populations for type 2 asthma biologics in a real-life population in Spain (BRAVO 2)

C. Domingo Ribas (Sabadell (Barcelona), Spain), A. Sogo Sagardia (Sabadell (Barcelona), Spain), D. Monserrate Mitchell (Sabadell (Barcelona), Spain), A. Sicras Mainar (Barcelona, Spain), A. Sicras Navarro (Barcelona, Spain), C. Engroba Teijeiro (Barcelona, Spain)

Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights
Session: Asthma pharmacology: clinical trials and mechanistic insights
Session type: Oral Presentation
Number: 3691

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Domingo Ribas (Sabadell (Barcelona), Spain), A. Sogo Sagardia (Sabadell (Barcelona), Spain), D. Monserrate Mitchell (Sabadell (Barcelona), Spain), A. Sicras Mainar (Barcelona, Spain), A. Sicras Navarro (Barcelona, Spain), C. Engroba Teijeiro (Barcelona, Spain). Late Breaking Abstract - Target populations for type 2 asthma biologics in a real-life population in Spain (BRAVO 2). 3691

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: